SynthesisHaematologica2023

Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.

Silvia Mangiacavalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.